Upstream Bio

Public

Waltham, MassachusettsBiotechhttps://www.upstreambio.com

Upstream Bio is now publicly traded

The data on this page reflects Upstream Bio's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series B

Jun 8, 2023

Total Funding Raised

$200M

Company Overview

Upstream Bio is a biotechnology company focused on developing innovative therapeutics for allergic and inflammatory diseases through its clinical-stage monoclonal antibody targeting the TSLP receptor.

Sector

Biotech

AI Layer

Non-AI

Keywords

TSLP receptor antagonistmonoclonal antibody for inflammatory diseaseupstream inflammatory pathway inhibitorlong-interval dosing biologicsevere asthma biologic therapychronic rhinosinusitis with nasal polyps (CRSwNP) therapychronic obstructive pulmonary disease (COPD) therapyinvestigational therapy for respiratory diseaseclinical-stage biopharmaceutical developmentpharmaceutical licensing and partnership model

Upstream Bio Comparables

Compare Upstream Bio with similar companies based on industry and business-model similarity.

Upstream Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
GSK plc	82%
Evommune	59%
Aer Therapeutics	53%

View all Comparables

Upstream Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jun 8, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Aaron Deykin

Chief Medical Officer and Head of Research and Development

Executive Team

Upstream Bio Investors

Notable investors and investment history

Upstream Bio investors
Investor	Rounds
Enavate Sciences	Series B
Bain Capital Life Sciences	Series B
TCG Crossover	Series B
Omega Funds	Series B
Altshuler Shaham Provident Funds and Pension Ltd.	Series B
OrbiMed	Series B
HBM Healthcare Investments	Series B

View all Investors

Upstream Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Upstream Bio Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersWaltham, Massachusetts

Employee Range74

Year Founded2021

Last FundingJun 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?